TAOK1 and metabolic dysfunction-associated steatohepatitis: Hepatocellular lipotoxicity is widely recognized as an initiating pathology in NAFLD/NASH.4 Thus, we analyzed the effect of modifying the abundance of TAOK1 on intracellular lipid accumulation in cultured human hepatocytes.